insights_auto
Prečo akcie NVZMF stúpli 6,12%?
Preskúmať podrobnejšiechevron_right
NVZMF:OTCMKTS
Novozymes A/S
69,35 USD
arrow_upward
+6,12%(+4,00) 1 d.
15. 10., 16:00:00 GMT-4 · USD
search
Všetky symboly
| Symbol | Cena | Zmena | % zmeny |
|---|
insights_autoGenerujú sa najdôležitejšie štatistiky pre NVZMF…
Otvoriť
69,26 USD
Vysoká
69,35 USD
Nízka
69,20 USD
Trh. kap.
183,47 mld.
Priem. obj.
550,00
Objem
368,00
Max. za 52 týž.
72,98 USD
Min. za 52 týž.
52,10 USD
Beta
0,82
Akcie v obehu
414,56 mil.
Počet zamestnancov
11 tis.
Otvoriť
69,26 USD
Vysoká
69,35 USD
Nízka
69,20 USD
Trh. kap.
183,47 mld.
Priem. obj.
550,00
Objem
368,00
Max. za 52 týž.
72,98 USD
Min. za 52 týž.
52,10 USD
Beta
0,82
Akcie v obehu
414,56 mil.
Počet zamestnancov
11 tis.
Spravodajstvo
Z internetových zdrojov a od spravodajských partnerov
ad-hoc-news.de
·
pred 16 hodinami
Novonesis stock stands 1.27 percent below its 52-week high
Profil
Novonesis is a biotechnology company headquartered in Lyngby, Denmark. Novonesis was formed in 2024 through the merger of Novozymes and Chr. Hansen.
The company develops enzymes, microbial cultures, and other biological products used in food and beverage production, household products, agriculture, and bioenergy.
The merger, first announced in December 2022, was the largest merger in history between two Danish companies. It would combine Novozymes' industrial-enzyme business with Chr. Hansen's microbial cultures and food-ingredient operations.
The company is publicly traded on Nasdaq Copenhagen and is part of the OMX Copenhagen 25 Index. The company's largest shareholder is Novo Holdings A/S, which is owned by the Novo Nordisk Foundation.
As of 2025, Novonesis has more than 11,000 employees and activities in over 45 countries. Wikipedia
Informácie o subjekte Novozymes A/S
Generálny riaditeľEster Baiget
Zamestnanci11,1 tis.
Dátum založenia2000
Hlavné sídlo-
OdvetvieSpeciality chemicals